International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 24-27 , July 2010

Antimicrobial resistance of Streptococcus pneumoniae in Southeast Austria, 1997–2008

  • M. Hoenigl

      Affiliations

    • Section of Infectious Diseases, Division of Pulmonology, Medical University of Graz, A-8010 Graz, Austria
    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • ,
  • P. Fussi

      Affiliations

    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • ,
  • G. Feierl

      Affiliations

    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • ,
  • U. Wagner-Eibel

      Affiliations

    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • ,
  • E. Leitner

      Affiliations

    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • ,
  • L. Masoud

      Affiliations

    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • ,
  • G. Zarfel

      Affiliations

    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • ,
  • E. Marth

      Affiliations

    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • ,
  • A.J. Grisold

      Affiliations

    • Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitaetsplatz 4, A-8010 Graz, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 316 380 4383; fax: +43 316 380 9650.

Received 20 February 2010 ,Accepted 1 March 2010.

References 

  1. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992;14:801–807
  2. EARSS Annual Report 2006. Bilthoven, The Netherlands: European Antimicrobial Resistance Surveillance System (EARSS); 2007. http://www.rivm.nl/earss/Images/EARSS%202006%20Def_tcm61-44176.pdf [accessed 15 November 2009].
  3. Fletcher MA, Laufer DS, McIntosh EDG, Cimino C, Malinoski FJ. Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?. Int J Clin Pract. 2006;60:450–456
  4. Sjöström K, Spindler C, Ortqvist A, Kalin M, Sandgren A, Kühlmann-Berenzon S, et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis. 2006;42:451–459
  5. Metz-Gercek S, Mittermayer H. The European surveillance activities EARSS and ESAC in the context of ABS International. Wien Klin Wochenschr. 2008;120:264–267
  6. Appelbaum PC. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis. 2002;34:1613–1620
  7. Arbique JC, Poyart C, Trieu-Cuot P, Quesne G, Carvalho Mda G, Steigerwalt AG, et al. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol. 2004;42:4686–4696
  8. Gardam MA, Miller MA. Optochin revisited: defining the optimal type of blood agar for presumptive identification of Streptococcus pneumoniae. J Clin Microbiol. 1998;36:833–834
  9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
  10. Pihlajamäki M, Jalava J, Huovinen P, Kotilainen P Finnish Study Group for Antimicrobial Resistance. Antimicrobial resistance of invasive pneumococci in Finland 1999–2000. Antimicrob Agents Chemother. 2003;47:1832–1835
  11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
  12. Jenkins SG, Brown SD, Farrell DJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US years 1–4. Ann Clin Microbiol Antimicrob. 2008;7:1
  13. Low DE. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news. Clin Infect Dis. 2005;41:228–233
  14. Shin JH, Jung HJ, Kim HR, Jeong J, Jeong SH, Kim S, et al. Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea. Antimicrob Agents Chemother. 2007;51:2625–2627
  15. EARSS Annual Report 2007. Bilthoven, The Netherlands: European Antimicrobial Resistance Surveillance System (EARSS); 2008. http://www.rivm.nl/earss/Images/EARSS%202007_FINAL_tcm61-55933.pdf [accessed 18 November 2009].
  16. EARSS Annual Report 2008. Bilthoven, The Netherlands: European Antimicrobial Resistance Surveillance System (EARSS); 2009. http://www.rivm.nl/earss/Images/EARSS%202008_final_tcm61-65020.pdf [accessed 11 December 2009].
  17. Buxbaum A, Forsthuber S, Graninger W, Georgopoulos A. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in Austria. J Antimicrob Chemother. 2004;54:247–250
  18. Metz-Gercek S, Maieron A, Strauss R, Wieninger P, Apfalter P, Mittermayer H. Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. BMC Infect Dis. 2009;9:61
  19. García-Suárez M, Villaverde R, Caldevilla AF, Méndez FJ, Vázquez F. Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococcal isolates in Asturias, Spain. Jpn J Infect Dis. 2006;59:299–305
  20. Lambertsen LM, Harboe ZB, Konradsen HB, Christensen JB, Hammerum AM. Non-invasive erythromycin-resistant pneumococcal isolates are more often non-susceptible to more antimicrobial agents than invasive isolates. Int J Antimicrob Agents. 2010;35:72–75
  21. Greenberg D, Givon-Lavi N, Sharf AZ, Vardy D, Dagan R. The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children. Pediatr Infect Dis. 2008;27:776–782
  22. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000, including a comparison of resistance rates since 1994–1995. Antimicrob Agents Chemother. 2001;45:1721–1729
  23. Marchese A, Tonoli E, Balistreri G, Debbia E, Schito GC. Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy. Microb Drug Resist. 2000;6:163–170
  24. Seral C, Castillo FJ, Rubio-Calvo MC, Fenoll A, Garcia C, Gomez-Lus R. Distribution of resistance genes tet(M), aph3′-III, catpC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain. J Antimicrob Chemother. 2001;47:863–866
  25. Riedel S, Beekmann E, Heilmann P, Richter SS, Gardia-deLomas J, Ferech M, et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 2007;26:485–490
  26. Mittermayer H, Jebelean C, Binder L, Haditsch M, Watschinger R. Antibiotic susceptibility of pneumococci isolated in Austria over a four-year period. Eur J Clin Microbiol Infect Dis. 1996;15:817–820
  27. Canton R, Morosini M, Enright MC, Morrissey I. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J Antimicrob Chemother. 2003;52:944–952
  28. Garcia-Rey C, Louie A, Deziel M, Gumbo T. Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. Clin Microbiol Infect. 2006;12:55–66
  29. Adam HJ, Schurek KN, Nichol KA, Hoban CJ, Baudry TJ, Laing NM, et al. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae in Canada, 1997 to 2005. Antimicrob Agents Chemother. 2007;51:198–207
  30. Reinert RR, Reinert S, Van der Linden M, Cil MY, Al-Lahham A, Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother. 2005;49:2903–2913
  31. Goldsmith CE, Moore JE, Murphy PG, Ambler JE. Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland. J Antimicrob Chemother. 1998;41:420–421
  32. Appelbaum PC, Gillespie SH, Burley CJ, Tillotson GS. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin. Int J Antimicrob Agents. 2004;23:533–546

☆ This manuscript was presented in part at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 12–15 September 2009, San Francisco, CA.

PII: S0924-8579(10)00115-9

doi: 10.1016/j.ijantimicag.2010.03.001

International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 24-27 , July 2010

Article Tools